| Pharmacists as accessible primary health care providers: review of the evidence RT Tsuyuki, NP Beahm, H Okada, YN Al Hamarneh Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 151 (1), 4-5, 2018 | 199 | 2018 |
| The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial RT Tsuyuki, YN Al Hamarneh, CA Jones, BR Hemmelgarn Journal of the American College of Cardiology 67 (24), 2846-2854, 2016 | 188 | 2016 |
| Pharmacist intervention for glycaemic control in the community (the RxING study) YN Al Hamarneh, T Charrois, R Lewanczuk, RT Tsuyuki BMJ open 3 (9), e003154, 2013 | 107 | 2013 |
| Public knowledge and awareness of cardiovascular disease and its risk factors: a cross-sectional study of 1000 Jordanians TL Mukattash, M Shara, AS Jarab, SI Al-Azzam, A Almaaytah, ... International Journal of Pharmacy Practice 20 (6), 367-376, 2012 | 92 | 2012 |
| Coronary heart disease: health knowledge and behaviour YN Al Hamarneh, GE Crealey, JC McElnay International journal of clinical pharmacy 33, 111-123, 2011 | 74 | 2011 |
| Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria GDE Cuvelier, ER Nemecek, JT Wahlstrom, CL Kitko, VA Lewis, ... Blood, The Journal of the American Society of Hematology 134 (3), 304-316, 2019 | 64 | 2019 |
| Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study M Donald, K King-Shier, RT Tsuyuki, YN Al Hamarneh, CA Jones, ... Canadian Medical Association Open Access Journal 5 (1), E205-E212, 2017 | 61 | 2017 |
| Pharmacists’ perceptions of their professional role: insights into hospital pharmacy culture YN Al Hamarneh, M Rosenthal, JC McElnay, RT Tsuyuki The Canadian journal of hospital pharmacy 64 (1), 31, 2011 | 48 | 2011 |
| The effectiveness of pharmacist interventions on cardiovascular risk in adult patients with type 2 diabetes: the multicentre randomized controlled RxEACH trial YN Al Hamarneh, BR Hemmelgarn, I Hassan, CA Jones, RT Tsuyuki Canadian journal of diabetes 41 (6), 580-586, 2017 | 43 | 2017 |
| Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study YN Al Hamarneh, K Johnston, CA Marra, RT Tsuyuki Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 152 (4), 257-266, 2019 | 34 | 2019 |
| Prevalence of non-adherence among psychiatric patients in Jordan, a cross sectional study TL Mukattash, KH Alzoubi, E Abu El-Rub, AS Jarab, SI Al-Azzam, ... International Journal of Pharmacy Practice 24 (3), 217-221, 2016 | 29 | 2016 |
| Community pharmacist targeted screening for chronic kidney disease YN Al Hamarneh, B Hemmelgarn, C Curtis, C Balint, CA Jones, ... Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 149 (1), 13-17, 2016 | 28 | 2016 |
| Effectiveness of pharmacist interventions on cardiovascular risk in patients with CKD: a subgroup analysis of the randomized controlled RxEACH Trial YN Al Hamarneh, RT Tsuyuki, CA Jones, B Manns, M Tonelli, ... American Journal of Kidney Diseases 71 (1), 42-51, 2018 | 27 | 2018 |
| Pharmacist prescribing and care improves cardiovascular risk, but what do patients think? A substudy of the RxEACH study YN Al Harmarneh, S Lamb, M Donald, B Hemmelgarn, K King Shier, ... Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 151 (4), 223-227, 2018 | 26 | 2018 |
| Pharmacists' perceptions of their practice: a comparison between Alberta and Northern Ireland YN Al Hamarneh, M Rosenthal, JC McElnay, RT Tsuyuki International Journal of Pharmacy Practice 20 (1), 57-64, 2012 | 24 | 2012 |
| Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update SA Lamb, YN Al Hamarneh, SKD Houle, AA Leung, RT Tsuyuki Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 151 (1), 33-42, 2018 | 23 | 2018 |
| Online clinical pathway for managing adults with chronic kidney disease C Curtis, C Balint, YN Al Hamarneh, M Donald, RT Tsuyuki, K McBrien, ... Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 148 (5), 257-262, 2015 | 19 | 2015 |
| Impact of COVID-19 on frontline pharmacists’ roles and services in Canada: the INSPIRE survey DH Lee, KE Watson, YN Al Hamarneh Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 154 (6), 368-373, 2021 | 17 | 2021 |
| Effectiveness of community pharmacist prescribing and care on cardiovascular risk reduction: randomized controlled RxEACH trial RT Tsuyuki, YN Al Hamarneh, CA Jones, BR Hemmelgarn J Am Coll Cardiol 67 (24), 2846-54, 2016 | 16 | 2016 |
| Glycemic control in community-dwelling patients with type 2 diabetes YN Al Hamarneh, M Rosenthal, RT Tsuyuki Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 145 (2), 68-69. e1, 2012 | 16 | 2012 |
